MedTrace Logo

Norspan® Patches Versus Tramadol in Subjects With Chronic, Moderate to Severe Osteoarthritis Pain in the Hip Knee and/or Lumbar Spine

NCT00426647 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2010-02-01

No results posted yet for this study

Summary

The primary objective of this equivalence study is to evaluate the efficacy of Norspan® patches versus Tramadol in subjects with chronic, moderate to severe osteoarthritis pain of the hip, knee and/or lumbar spine.

The secondary objectives are to evaluate the safety and general satisfaction for the patients in the two treatment groups.

Conditions

Interventions

DRUG

Buprenorphine

DRUG

Tramadol

Sponsors & Collaborators

  • Mundipharma Finland

    collaborator UNKNOWN

  • Norpharma A/S

    lead INDUSTRY

Principal Investigators

  • Dorthe Tvinnemose, DVM · Norpharma A/S, Slotsmarken 15, DK-2970 Hoersholm, Denmark

  • Kim H Kristiansen, DM · GP, Noerretorv 10, DK-7200 Grindsted, Denmark

  • Olavi Airaksinen, DM · Oma Lääkäri Oy, Vuorikatu 20, FIN-70100 KUOPIO

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2009-07-31
Completion
2009-08-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00426647 on ClinicalTrials.gov